Iovance Biotherapeutics, Inc. (IOVA) - Stock Prices, Stock Peers & Analysis

Home
IOVA

Company Name	Iovance Biotherapeutics, Inc.
Symbol	IOVA
Currency	USD
Price	10.34
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	3,138,334,760
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	3.21 - 18.33
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Website	https://www.iovance.com

An error occurred while fetching data.

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma;